Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The combination therapy was effective and well-tolerated, especially in young patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Baricitinib may effectively treat oral lichen planus.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Tofacitinib may help treat severe hair loss, but more research is needed.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The model and estimator can predict drug exposure in kidney transplant patients well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Alopecia areata treatment varies, with no optimal method established yet.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Apremilast was not effective in treating moderate-to-severe alopecia areata.